openPR Logo
Press release

Global 3D Cell Culture System Market, Trends, Analysis, Opportunities, Share and Forecast – 2019-2025

01-15-2020 01:48 PM CET | Health & Medicine

Press release from: Digitsnmarkets

3D Cell Culture System Market

3D Cell Culture System Market

The growth in the Cell Culture market is primarily driven by the rising global R&D investments in cell-based research by pharmaceutical & biotechnology companies. The total worldwide R&D spend of pharmaceutical and biotechnology companies amounts to USD 150 billion, the global average R&D rate (R&D as a percent of sales) of pharma and biotech companies is 10.6 % (for the big players up to 20 %)in 2017.
Along with the rising investments in R&D, the rise in need for organ transplantation has boosted the use of 3D cell culture system models as an alternative tool for in vivo testing and increasing focus on regenerative medicine are key factors propelling the growth of the market during the forecast period. On the other hand, the expenses of the system and technologies associated with the 3D cell culture system and the lack of experienced and skilled professionals are expected to limit market growth during the forecast period.
 
“The 3D cell culture system market is estimated to be USD XX million in 2018 and it is expected to reach more than USD 1,768 million by 2025, likely to grow at a CAGR of xx% during the forecast period”
 
To request a sample copy or view summary of this report, click the link below:
http://www.digitsnmarkets.com/sample/3799-3d-cell-culture-system-market

The scaffold-based 3D cell culture segment accounted for the largest share of the global 3D cell culture market. The scaffold-based segment holds the largest market share in the global market in the product segment. The use of hydrogels in the scaffold-based 3D cell culture is the key factor driving the scaffold-based segment, as they can be derived naturally from protein and ECM components.
Biotech and pharma companies dominated the 3D cell culture system market with over 47.0% revenue share in 2018 in the end-user segment. An increase in R&D spending and investment made by a large number of pharmaceutical & biotechnology companies will boost the 3D
cell culture system market. Also, the growing preference for alternative testing models over animal techniques are the key market drivers in this end-user segment.

Europe is expected to grow at the highest CAGR during the forecast period. The biotech industry in Europe spends nearly USD7.32 billion in R&D and USD23.2 billion in revenue. The average size of biotech in Europe had grown to USD165 million with a CAGR of 21.2 % since 2012. Growing investments for Research and Development in the Healthcare sector would be the key factor for regional growth.

Thermo Fisher Scientific (US) is the leading player in the 3D cell culture system. The company has the largest market share in the 3D cell culture system market. It has acquired the advanced bioprocessing business of BD (US) in October 2018, to enhance its presence in the 3D cell culture systems market.

Many companies are also entering into this segment due to the increase in demand for the 3D cell culture, Some of the major companies into 3D cell culture are  Corning Incorporated (US), Hµrel Corporation (US), QGel SA (Switzerland), SynVivo (US), Advanced BioMatrix (US), Greiner Bio-One International (Austria), Merck KGaA (Germany), Lonza AG (Switzerland), REPROCELL Incorporated (Japan), TissUse (Germany), InSphero (Switzerland), Synthecon (US), 3D Biotek (US), CN Bio (UK), Hamilton Company (US), MIMETAS (Netherlands), Emulate (US), and PromoCell (Germany).

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: sales@digitsnmarkets.com
Website:- www.digitsnmarkets.com

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global 3D Cell Culture System Market, Trends, Analysis, Opportunities, Share and Forecast – 2019-2025 here

News-ID: 1897111 • Views:

More Releases from Digitsnmarkets

Global Diabetic Neuropathy Treatment Market , Trends, Analysis, Opportunities, Share and Forecast – 2019-2025
Global Diabetic Neuropathy Treatment Market , Trends, Analysis, Opportunities, S …
Diabetic neuropathy cases are increasing worldwide, fueling the market growth. Diabetic neuropathy treatment is the second-highest contributor to global disability and an estimated 30% to 40% of people worldwide live with diabetic neuropathy. It is the most common illness in low- and middle-income countries which is the majority of the world, and this disorder requires lifelong care to manage. Thus Diabetic neuropathy treatment is one the most demand market in
Global Diphtheria Vaccine Market , Trends, Analysis, Opportunities, Share and Forecast – 2019-2025
Global Diphtheria Vaccine Market , Trends, Analysis, Opportunities, Share and Fo …
The growing incidence of diphtheria, tetanus, and pertussis coupled with rising worldwide governmental support for the vaccination programs are anticipated to drive the global DTaP vaccine market. Even though factors such as growing demand for the DTaP vaccine, rising Incidences of diphtheria, tetanus, and pertussis as well as raising awareness pertaining to the advantages of inoculation are driving global diphtheria, pertussis, and tetanus (DTaP) vaccine market. The scattered incidences of
Global DNA Vaccine Market , Trends, Analysis, Opportunities, Share and Forecast – 2019-2025
Global DNA Vaccine Market , Trends, Analysis, Opportunities, Share and Forecast …
The global DNA vaccines market is experiencing significant growth because of factors such as the adoption of DNA vaccines in healthcare, low costs of DNA vaccines, and increasing investments in DNA technology. The increase in the prevalence of chronic diseases such as cancer, hepatitis, HIV and others is stimulating the growth of the global DNA vaccine market. Ease of large-scale manufacturing compared to the traditional approach and less storage requirement
Global Drone Market , Trends, Analysis, Opportunities, Share and Forecast – 2019-2025
Global Drone Market , Trends, Analysis, Opportunities, Share and Forecast – 20 …
Increasing the use of drones in commercial sectors such as media and entertainment, inspection, monitoring, surveying, and mapping is stimulating demand for drones. Governments all over the world are also implementing drones in public safety services, drones are widely used by law and enforcement agencies for surveillance that is stimulating its market. Drones are also used in infrastructure, scientific research and R&D, environmental studies, and disaster management activities. A

All 5 Releases


More Releases for R&D

Siveco doubles China R&D investment
On July 3, 2019, Siveco China held its half-year management meeting at the prestigious Hellas House in Shanghai, a nod to the company's continuing growth on the Belt & Road. With financial results above target, high customer satisfaction (as shown in the latest audited customer satisfaction survey) and a sales pipeline more promising than ever, the company's management board announced that shareholders have approved its request for additional investment in
R&D Collaborative Projects by GD Rectifiers
GD Rectifiers have extensive experience in collaborative R&D projects and are proud to work with some of the UK’s pioneering power electronic companies to drive design and innovation forward. This R&D service helps drive GD Rectifiers forward as a cutting edge manufacturer embracing fundamental technologies that support product development that contribute to next generation products throughout: renewable energy, embedded systems, smart metrering and the rail industry. Power Assemblies, Controllers and
Transforming Pharmaceutical R&D with Data
ReportsWorldwide has announced the addition of a new report title Transforming Pharmaceutical R&D with Data to its growing collection of premium market research reports. Transforming Pharmaceutical R&D with Data In the current drug pricing environment, biopharmaceutical firms cannot afford to continue spending billions of dollars on development programs that are more than 90% likely to fail. Raising prices to compensate for expensive, risky research and development (R&D) is no longer an option
Noliac is expanding the R&D team
Noliac is looking for two new colleagues for the R&D team in Prague, Czech Republic: A Precision/Fine Mechanics and an Electroengineer. Precision/Fine Mechanics For the R&D team in Prague, Czech Republic, Noliac is looking for a Precision/Fine mechanics to work on modifying existing products and work with developing new. Noliac requires a colleague who: Is mechanically skilled with a focus on very small machinery. Holds a technical high school degree or an apprenticeship
Leiber GmbH further invests in R&D
Since February 2016, Leiber GmbH has been reinforced by Dr med vet Claudia Westfahl - a veterinarian specialized in animal nutrition - as part of the company's strategy to invest in new product developments. With the new position ‘Product Development Animal Nutrition’, Dr Westfahl is responsible for new product development in the field of functional feed ingredients for both pet as well as farm animals. After graduating at the University
Rising R&D Funding for Nanotechnology
Global nanotechnology market has been registering marked increase in funds allocation by the countries across the world, especially with new product development that received huge momentum due to these funding. An increase in global public funding for R&D initiatives supports quick commercialization of nano-based products. Fundings from governments, corporations, and venture capital exhibited a CAGR growth of 1% during 2008-2012. In future, it is expected that nanotechnology funding will grow